Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network... Show more
Cypherpunk Technologies occupies a distinctive niche as a Nasdaq-listed vehicle built around Zcash (ZEC), a privacy-focused cryptocurrency. The company, formerly known as Leap Therapeutics before its November 2025 rebrand, now pursues its mission through two primary strategies: accumulating ZEC as a corporate treasury reserve and investing in, acquiring, and building privacy-enhancing technologies. This dual mandate makes Cypherpunk one of the few public-market routes for investors seeking direct, equity-style exposure to a single privacy-focused digital asset and its underlying network infrastructure.
The acquisition of a mining operation from Winklevoss Capital in a $33.33 million equity transaction materially strengthened its competitive positioning. By controlling roughly 18% of total Zcash network hashrate (computing power used to secure the network and earn newly minted coins), Cypherpunk has shifted from a passive holder to an active network participant. Management frames this as a way to produce ZEC at costs below market price, providing financial and operational flexibility to fund future ZEC purchases and new privacy-technology investments. Its stated ambition to reach 5% of ZEC's total supply positions it as a benchmark holder that could influence market dynamics, though this also concentrates risk in a single asset.
Several forward-looking catalysts could shape investor sentiment. The next quarterly earnings release, estimated for November 2026, will be closely watched because the company marks its ZEC treasury holdings to market each period, meaning results can swing sharply with token prices. Guidance on treasury accumulation progress toward the 5% goal and early mining economics will be key disclosures.
On the analyst front, coverage has become notably more optimistic. Cantor Fitzgerald initiated coverage with an Overweight rating in July 2026 and subsequently raised its price target in stages, most recently to $4.90 in September 2026. This has lifted the consensus 12-month price target to approximately $4.90, reflecting growing confidence in the treasury-plus-mining model. Continued target revisions and any expansion of analyst coverage will be important sentiment drivers.
Network-level developments also matter. The Zcash protocol's July 2026 Ironwood upgrade replaced the Orchard shielded pool to address a previously identified vulnerability, and further protocol upgrades or institutional adoption of privacy-preserving technology could reinforce the strategic thesis. Finally, the company's $200 million at-the-market equity facility and expanded share authorization signal a capital-raising capacity that could fund further ZEC accumulation, though at the cost of potential dilution.
Cypherpunk's trajectory is tightly linked to digital-asset market conditions. ZEC's price is the single largest driver of reported earnings and book value, so broader cryptocurrency sentiment, liquidity conditions, and risk appetite all flow directly into the company's financials. Interest-rate policy matters as well: lower rates and ample liquidity have historically supported risk assets, including cryptocurrencies, while tighter financial conditions can pressure token valuations and, in turn, Cypherpunk's marked-to-market results.
Regulatory climate is a defining variable. Privacy coins face heightened scrutiny from regulators concerned about illicit-finance risks, and any restrictive policy toward privacy-focused assets could weigh on demand and institutional participation. Conversely, a clearer or more accommodating U.S. framework for digital assets could broaden adoption and support the value of Cypherpunk's holdings. Energy costs and mining economics also shape the profitability of its mining fleet, while continued technological adoption of zero-knowledge and privacy-preserving systems underpins the long-term demand story.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, exchange-traded fund (ETF), or other asset may move bullish, bearish, or sideways over the coming week or month. It is built to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking volatile, event-driven names such as Cypherpunk Technologies, tools like the Trend Prediction Engine can add a data-driven layer to their market analysis.
Looking toward 2026 and beyond, Cypherpunk's outlook hinges on its ability to execute a concentrated digital-asset strategy while managing volatility and dilution. Continued progress toward its 5% ZEC supply target would deepen its status as a leading corporate holder, potentially amplifying upside in favorable markets but also magnifying downside risk. The mining vertical introduces a recurring production element that could smooth cash flows over time and reduce reliance on outright token purchases.
Longer term, the evolution of the privacy-technology sector is the core structural driver. As concerns about data privacy and digital surveillance grow, demand for privacy-preserving networks and zero-knowledge technologies could expand the addressable market beyond a single token. The company's stated intent to invest in additional privacy-enhancing technologies could gradually diversify its exposure. However, competitive threats from other privacy-focused blockchains, protocol security risks, regulatory shifts, and the ongoing use of equity issuance to fund growth all represent meaningful variables. Consensus analyst expectations, reflected in an average 12-month price target near $4.90, suggest a constructive view, but the wide dispersion of outcomes inherent in a single-asset, high-volatility business model warrants caution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ECH | 37.78 | 0.05 | +0.13% |
| iShares MSCI Chile ETF (ECH) | |||
| TLT | 78.05 | 0.07 | +0.09% |
| iShares 20+ Year Treasury Bond ETF (TLT) | |||
| DBEZ | 61.09 | N/A | N/A |
| Xtrackers MSCI Eurozone Hedged Equity ETF (DBEZ) | |||
| HECA | 27.29 | -0.08 | -0.29% |
| Hedgeye Capital Allocation ETF | |||
| TSEP | 26.69 | -0.17 | -0.62% |
| FT Vest Emerging Market Buffer ETF - September (TSEP) | |||
A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.
| Ticker / NAME | Correlation To CYPH | 1D Price Change % | ||
|---|---|---|---|---|
| CYPH | 100% | +4.63% | ||
| INKT - CYPH | 42% Loosely correlated | -3.07% | ||
| AXON - CYPH | 40% Loosely correlated | +1.34% | ||
| SABS - CYPH | 36% Loosely correlated | +3.11% | ||
| AMRN - CYPH | 35% Loosely correlated | +0.33% | ||
| DFDV - CYPH | 32% Poorly correlated | -1.53% | ||
More | ||||
| Ticker / NAME | Correlation To CYPH | 1D Price Change % |
|---|---|---|
| CYPH | 100% | +4.63% |
| Investment Managers industry (134 stocks) | 2% Poorly correlated | -0.59% |
a company, which engages in clinical stage immuno-oncology
Industry InvestmentManagers
The 50-day moving average for CYPH moved above the 200-day moving average on September 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYPH advanced for three days, in 211 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Aroon Indicator entered an Uptrend today. In 126 of 149 cases where CYPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The 10-day RSI Indicator for CYPH moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 23 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYPH as a result. In 67 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CYPH turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 33 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
CYPH broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CYPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.560) is normal, around the industry mean (3.263). P/E Ratio (5.169) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). CYPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.081). P/S Ratio (0.000) is also within normal values, averaging (15.860).